CABA: Cabaletta Bio, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
PEG koeffitsiyenti tarixi Cabaletta Bio, Inc. (CABA) kompaniyasining baholash dinamikasini aks ettiradi, bunda ushbu ko'rsatkich 0.00 darajasida turibdi. Emitentning daromadlari og'ir autoimmun patologiyalarga qarshi kurashish uchun CART terapiyalarini joriy etishga asoslangan. Cabaletta Bio, Inc. (CABA) bio-chiqindilarni utilizatsiya qilishning ekologik standartlariga va tadqiqot etikalariga rioya qiladi. Biznesning rivojlanishi M&A tranzaksiyalarini amalga oshirmagan holda, organik o'sishga va klinikalarga bo'lgan sherikliklarga tayanadi.
Cabaletta Bio, Inc. (CABA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Cabaletta Bio, Inc.|CABA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi cabalettabio.com|CABA - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Cabaletta Bio, Inc|CABA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Cabaletta Bio, Inc.|Tezkor likvidlik koeffitsiyenti cabalettabio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CABA - Sof foyda|Kutilayotgan foyda Cabaletta Bio, Inc.|CABA - P/E multiplikatori|Forvard P/E multiplikatori Cabaletta Bio Inc|CABA - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Cabaletta Bio, Inc|CABA - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Cabaletta Bio, Inc.|CABA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati cabalettabio.com|CABA - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Cabaletta Bio, Inc.
Kompaniyaning umumiy tahlili:CABA - Cabaletta Bio Inc.
PEG koeffitsiyenti P/E ko'rsatkichi va foyda o'sish sur'atlarini taqqoslaydi, bu esa qiymat birdan past bo'lganda, qadrsizlangan aktivlarni aniqlash imkonini beradi. P/E balansi va o'sishga tegishli 0.00 ning joriy darajasi, autoimmun kasalliklar uchun CAR-T terapiyasi bo'yicha yetakchilik poygasida CARTA platformasining salohiyatiga nisbatan Cabaletta Bio, Inc. (CABA) kompaniyasining bozor qiymatini aks ettiradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|Pharvaris Pharma (PHVS) - Narx-foyda va o‘sish multiplikatori|ABCL: PEG multiplikatori|tourmalinebio.com (TRML) - PEG multiplikatori|PGEN (Precigen) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati PHAR|PEG multiplikatori NKTR|PEG multiplikatori Upstream Pharma (UPB)|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|immunome.com - Narxning foydaga va o‘sish sur’atiga nisbati|Gossamer Bio - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda KalVista Pharma|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|PVLA: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori SVRA|RIGL (rigel.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori ANAB|PEG multiplikatori Astria Therapeutics Inc (ATXS)|enGene Bio - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti RAPT|Aerovate - PEG multiplikatori|ACRS: Narxning foydaga va o‘sish sur’atiga nisbati|KYTX: PEG multiplikatori|TLSA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Ventyx Bio|O‘sish sur’atiga tuzatilgan narx-foyda Theratechnologies, Inc THTX|Narx-foyda va o‘sish multiplikatori AVTX (Avalo Therapeutics, Inc)|ELDN (eledon.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AGEN (Agenus Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Climb Bio Inc. (CLYM)|ZURA - Narxning foydaga va o‘sish sur’atiga nisbati|ATYR (aTyr Pharmaceuticals) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ADAG: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Ikena Oncology|Narx-foyda va o‘sish multiplikatori STTK|Equillium Bio (EQ) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori CNTB|Narx-foyda va o‘sish multiplikatori immunic-therapeutics.com IMUX|PEG multiplikatori ATRA (Atara Bio)|PEG multiplikatori InflaRx NV IFRX|X4 Pharmaceuticals, Inc. - PEG multiplikatori|ACET: Narxning foydaga va o‘sish sur’atiga nisbati|CELU: PEG multiplikatori|INmune Bio Corporation (INMB) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|kezarlifesciences.com - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori SABS|AKTX (Akari Therapeutics PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|PEG multiplikatori Q32 Bio Inc QTTB|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (edesabiotech.com)|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Carisma Therapeutics Inc.|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|PEG multiplikatori Bolt Bio|Narx-foyda va o‘sish multiplikatori HCWB (HCW Biologics Inc.)|APVO (aptevotherapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AIM (AIM ImmunoTech)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aditxt Inc. (ADTX)|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narx-foyda va o‘sish multiplikatori INDP|PEG multiplikatori Scinai Immunotherapeutics Ltd|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|affimed.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ALLK (Allakos)|HOOKIPA Pharma, Inc. (HOOK) - O‘sish sur’atiga tuzatilgan narx-foyda|IGM Bio - PEG multiplikatori|iTeos Therapeutics Inc (ITOS) - Narx-foyda va o‘sish multiplikatori|OCEA: PEG multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|THRD (Third Harmonic Bio) - PEG multiplikatori
